- Home
- / AdoRx Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
AdoRx Therapeutics financials data including stock price, CreditSafe score, and balance sheet.
Total Funding
$10 M
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 |
|---|---|---|
| Cash | 276.1K | 7.2M |
| Current Assets | 301.3K | 7.9M |
| PP&E | 666.0 | 3.1K |
| Total Assets | 305.2K | 7.9M |
| Accounts Payable | 102.3K | 675.2K |
| Current Liabilities | 154.0K | 6.2M |
| Non-Current Liabilities | 1.3M | 5.2M |
| Total Liabilities | 1.5M | 11.4M |
| Common Stock | 28.0 | |
| Retained Earnings | (1.4M) | (3.5M) |
| Total Equity | (1.2M) | (3.5M) |
| Financial Leverage | -0.3 | -2.2 |